Clade Therapeutics

Clade Therapeutics

Come and join biomodal at Clade Therapeutics
29 September 2023
to 29 September 2023
12:00 pm
to 1:30 pm
BST
Clade Therapeutics/Landmark Center
, Boston

About the event

Talk details: Maximising your omic research: generating more information from limited amounts of DNA

Speaker: Mark Consugar, Lead Field Application Scientist at bimodal.

  • Preserve valuable samples: utilise samples as low as 10ng of DNA for highly accurate modC. 
  • C-to-T mutation detection: simultaneously detect the most common type of genetic mutation (C-to-T) in the human genome and cancer.  
  • Whole genome investigation: get simultaneous whole genome sequencing results with standard SNP detection and epigenetic marks with improved sensitivity and specificity.  
  • Allele-specific methylation: attain phased results for allele-specific methylation (ASM) and maintain even genomic coverage. 
  • Seamless bioinformatics integration: gain a fully optimised bioinformatics pipeline using existing alignment and SNP calling, plus a proprietary module for epigenetic and ASM quantification.

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Attending from biomodal

John McShane
Director, Business Development – East Coast USA and Canada

Register now

clade therapeutics 2023

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal